|March 25, 2014||Could adipose tissue inflammation eventually be considered as a relevant therapeutic target?||Ulf Smith, MD, PhD, Professor of Internal Medicine, The Lundberg Laboratory for Diabetes Research, Center of Excellence for Cardiovascular and Metabolic Research, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.||Expert Opinions
Video 1:08 min.
|March 11, 2014||Could you comment on the link between statin use and the risk of developing type 2 diabetes?||Kwang Kong Koh, MD, PhD, FACC, FAHA, Professor, Vascular Medicine and Atherosclerosis Unit Cardiology, Gachon University Gil Medical Center, Incheon, South Korea||Expert Opinions
Video 1:28 min.
|February 25, 2014||What is in your opinion the future of cardiovascular disease prevention?||Eric Larose, DVM, MD, Adjunct Professor, Multidisciplinary Department of Cardiology, Institut universitaire de cardiologie et de pneumologie de Québec, Faculty of Medicine, Université Laval, Québec, QC, Canada||Expert Opinions
Video 1:00 min.
|February 11, 2014||Do you think that nutraceutical products have a real impact on cardiovascular health?||Benoît Lamarche, PhD, Professor, Institute of Nutraceuticals and Functional Foods, Université Laval, Québec, QC, Canada||Expert Opinions
Video 0:42 min.
|January 28, 2014||Worldwide, what are the common features of a healthy diet?||Christopher Gardner, PhD, Director, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, LA, USA||Expert Opinions
Video 0:55 min.
|January 14, 2014||In the present world, how do you see the challenge of improving nutritional and physical activity habits in patients with type 2 diabetes managed in primary care?||Edward Horton, MD, Joslin Diabetes Center, Boston, MA, USA||Expert Opinions
Video 2:27 min.
|January 01, 2014||How, why and what should we do in clinical practice to implement physical activity exercise programs successfully?||Robert Ross, PhD, Professor, School of Kinesiology and Health Studies, Department of Medicine, Division of Endocrinology and Metabolism, Queen's University, Kingston, ON, Canada||Expert Opinions
Video 3:20 min.
|December 17, 2013||How do you see the future of optimal CVD risk assessment and management in patients with type 2 diabetes?||Darren McGuire, MD, MHSC, Division of Cardiology and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA||Expert Opinions
Video 0:41 min.
|December 03, 2013||How do you see adipose tissue as a target for the management of cardiometabolic risk?||Michael Jensen, MD, Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA||Expert Opinions
Video 0:51 min.
|November 19, 2013||Could you elaborate on the multiple target therapies to manage high-risk patients with abdominal obesity and the metabolic syndrome?||Kwang Kong Koh, MD, PhD, FACC, FAHA, Professor, Vascular Medicine and Atherosclerosis Unit Cardiology, Gachon University Gil Medical Center, Incheon, South Korea||Expert Opinions
Video 0:52 min.
The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.